| |
| |
|
| Insider
Information: |
Gardiner Nathaniel S. |
| Relationship: |
Chief Legal Officer |
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
75,688 |
|
|
Indirect Shares
|
35,926 |
|
|
| Direct
Value |
$1,026,329 |
|
|
|
Indirect Value
|
$487,157 |
|
|
| Total
Shares |
111,614 |
|
|
| Total
Value |
$1,513,486 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 31.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Enanta Pharmaceuticals Inc |
ENTA |
Chief Legal Officer |
2024-02-26 |
75,688 |
2024-02-26 |
35,926 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ENTA |
Enanta Pharmaceuticals In... |
Chief Legal Officer |
• – – |
2024-02-26 |
4 |
OE |
$8.99 |
$46,631 |
D/D |
5,187 |
75,688 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Legal Officer |
• – – |
2024-02-12 |
4 |
D |
$12.41 |
$12,075 |
D/D |
(973) |
70,501 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Legal Officer |
• – – |
2024-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,320 |
71,474 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2023-12-05 |
4 |
S |
$9.63 |
$23,228 |
D/D |
(2,412) |
68,154 |
0 |
% |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2023-12-01 |
4 |
D |
$9.49 |
$15,137 |
D/D |
(1,595) |
70,566 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2023-04-18 |
4 |
OE |
$30.00 |
$200,010 |
D/D |
6,667 |
79,980 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2023-02-13 |
4 |
D |
$52.77 |
$355,406 |
D/D |
(6,735) |
73,313 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
20,997 |
80,048 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2022-12-01 |
4 |
D |
$44.33 |
$46,768 |
D/D |
(1,055) |
59,051 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2022-11-23 |
4 |
A |
$0.00 |
$0 |
D/D |
21,000 |
60,106 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2022-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,034 |
47,196 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2022-02-14 |
4 |
D |
$62.49 |
$59,803 |
D/D |
(957) |
46,239 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2021-12-01 |
4 |
D |
$87.68 |
$48,838 |
D/D |
(557) |
59,226 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2021-11-19 |
4 |
A |
$0.00 |
$0 |
D/D |
6,800 |
59,783 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2020-12-15 |
4 |
D |
$42.52 |
$65,481 |
D/D |
(1,540) |
42,248 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2020-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,250 |
43,788 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2020-12-03 |
4 |
OE |
$30.00 |
$50,010 |
D/D |
1,667 |
38,538 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2020-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
7,600 |
36,871 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2020-08-05 |
4 |
OE |
$30.00 |
$49,980 |
D/D |
1,666 |
29,271 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2020-03-12 |
4 |
OE |
$30.00 |
$90,000 |
D/D |
3,000 |
27,605 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2020-02-12 |
4 |
D |
$52.76 |
$49,594 |
D/D |
(940) |
24,605 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2020-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,887 |
25,545 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2019-12-16 |
4 |
D |
$63.88 |
$148,904 |
D/D |
(2,331) |
22,658 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2019-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,250 |
24,989 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2019-11-22 |
4 |
OE |
$31.42 |
$50,021 |
D/D |
1,592 |
19,739 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
